Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Originally published in Science Express on 14 March 2002
Science 12 April 2002:
Vol. 296. no. 5566, pp. 356 - 359
DOI: 10.1126/science.1068284
Prev | Table of Contents | Next

Reports

Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus

Olen Kew,1* Victoria Morris-Glasgow,2 Mauricio Landaverde,3 Cara Burns,1 Jing Shaw,1 Zacarías Garib,4 Jean André,5 Elizabeth Blackman,2 C. Jason Freeman,1 Jaume Jorba,1 Roland Sutter,6 Gina Tambini,3 Linda Venczel,3 Cristina Pedreira,7 Fernando Laender,8 Hiroyuki Shimizu,9 Tetsuo Yoneyama,9 Tatsuo Miyamura,9 Harrie van der Avoort,10 M. Steven Oberste,1 David Kilpatrick,1 Stephen Cochi,6 Mark Pallansch,1 Ciro de Quadros3

An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.

1 Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, Atlanta, GA 30333, USA.
2 Caribbean Epidemiology Centre (CAREC) Laboratory, Pan American Health Organization (PAHO), 16-18 Jamaica Boulevard, Federation Park, Port-of-Spain, Trinidad and Tobago.
3 Division of Vaccines and Immunization, PAHO, 525 Twenty-Third Street, N.W., Washington, DC 20037, USA.
4 Ministry of Health, Avenida San Cristóbal esquina Tiradentes, Santo Domingo, Dominican Republic.
5 Ministry of Public Health, Port-au-Prince, Haiti.
6 Vaccine Preventable Disease Eradication Division, National Immunization Program, CDC, 1600 Clifton Road, Atlanta, GA 30333, USA.
7 PAHO, Calle Pepillo Salcedo, Plaza de la Salud, Santo Domingo, Dominican Republic.
8 PAHO, Number 295 Avenue John Brown, Port-au-Prince, Haiti.
9 Department of Virology II, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162, Japan.
10 Polio Laboratory, National Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3720 BA, Bilthoven, Netherlands.
*   To whom correspondence should be addressed. E-mail: okew{at}cdc.gov

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages.
C. Savolainen-Kopra, E. Samoilovich, H. Kahelin, A.-K. Hiekka, T. Hovi, and M. Roivainen (2009)
J. Gen. Virol. 90, 1859-1868
   Abstract »    Full Text »    PDF »
Rapid Group-, Serotype-, and Vaccine Strain-Specific Identification of Poliovirus Isolates by Real-Time Reverse Transcription-PCR Using Degenerate Primers and Probes Containing Deoxyinosine Residues.
D. R. Kilpatrick, C.-F. Yang, K. Ching, A. Vincent, J. Iber, R. Campagnoli, M. Mandelbaum, L. De, S.-J. Yang, A. Nix, et al. (2009)
J. Clin. Microbiol. 47, 1939-1941
   Abstract »    Full Text »    PDF »
Impact of Exogenous Sequences on the Characteristics of an Epidemic Type 2 Recombinant Vaccine-Derived Poliovirus.
F. B. Riquet, C. Blanchard, S. Jegouic, J. Balanant, S. Guillot, M.-A. Vibet, M. Rakoto-Andrianarivelo, and F. Delpeyroux (2008)
J. Virol. 82, 8927-8932
   Abstract »    Full Text »    PDF »
The Risks, Costs, and Benefits of Possible Future Global Policies for Managing Polioviruses.
K. M. Thompson, R. J. D. Tebbens, M. A. Pallansch, O. M. Kew, R. W. Sutter, R. B. Aylward, M. Watkins, H. E. Gary Jr, J. Alexander, H. Jafari, et al. (2008)
Am J Public Health 98, 1322-1330
   Abstract »    Full Text »    PDF »
Virus Attenuation by Genome-Scale Changes in Codon Pair Bias.
J. R. Coleman, D. Papamichail, S. Skiena, B. Futcher, E. Wimmer, and S. Mueller (2008)
Science 320, 1784-1787
   Abstract »    Full Text »    PDF »
Calibration of Multiple Poliovirus Molecular Clocks Covering an Extended Evolutionary Range.
J. Jorba, R. Campagnoli, L. De, and O. Kew (2008)
J. Virol. 82, 4429-4440
   Abstract »    Full Text »    PDF »
Multiple recombinant dengue type 1 viruses in an isolate from a dengue patient.
J. Aaskov, K. Buzacott, E. Field, K. Lowry, A. Berlioz-Arthaud, and E. C. Holmes (2007)
J. Gen. Virol. 88, 3334-3340
   Abstract »    Full Text »    PDF »
Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece.
E. Dedepsidis, Z. Kyriakopoulou, V. Pliaka, C. Kottaridi, E. Bolanaki, S. Levidiotou-Stefanou, D. Komiotis, and P. Markoulatos (2007)
Appl. Envir. Microbiol. 73, 6697-6704
   Abstract »    Full Text »    PDF »
Enterovirus surveillance reveals proposed new serotypes and provides new insight into enterovirus 5'-untranslated region evolution.
T. Smura, S. Blomqvist, A. Paananen, T. Vuorinen, Z. Sobotova, V. Bubovica, O. Ivanova, T. Hovi, and M. Roivainen (2007)
J. Gen. Virol. 88, 2520-2526
   Abstract »    Full Text »    PDF »
Shedding and Reversion of Oral Polio Vaccine Type 3 in Mexican Vaccinees: Comparison of Mutant Analysis by PCR and Enzyme Cleavage to a Real-Time PCR Assay.
D. Gnanashanmugam, M. S. Falkovitz-Halpern, A. Dodge, M. Fang, L. J. Wong, M. Esparza, R. Hammon, E. E. Rivas-Merelles, J. I. Santos, and Y. Maldonado (2007)
J. Clin. Microbiol. 45, 2419-2425
   Abstract »    Full Text »    PDF »
Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication.
P. Jiang, J. A. J. Faase, H. Toyoda, A. Paul, E. Wimmer, and A. E. Gorbalenya (2007)
PNAS 104, 9457-9462
   Abstract »    Full Text »    PDF »
Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba.
The Cuba IPV Study Collaborative Group (2007)
N. Engl. J. Med. 356, 1536-1544
   Abstract »    Full Text »    PDF »
Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples.
N. I. Romanenkova, S. Guillot, N. R. Rozaeva, R. Crainic, M. A. Bichurina, and F. Delpeyroux (2006)
J. Clin. Microbiol. 44, 4077-4084
   Abstract »    Full Text »    PDF »
Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication..
A. J. Macadam, G. Ferguson, D. M. Stone, J. Meredith, S. Knowlson, G. Auda, J. W. Almond, and P. D. Minor (2006)
J. Virol. 80, 8653-8663
   Abstract »    Full Text »    PDF »
Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region..
C. C. Burns, J. Shaw, R. Campagnoli, J. Jorba, A. Vincent, J. Quay, and O. Kew (2006)
J. Virol. 80, 3259-3272
   Abstract »    Full Text »    PDF »
Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties.
M. L. Yakovenko, E. A. Cherkasova, G. V. Rezapkin, O. E. Ivanova, A. P. Ivanov, T. P. Eremeeva, O. Y. Baykova, K. M. Chumakov, and V. I. Agol (2006)
J. Virol. 80, 2641-2653
   Abstract »    Full Text »    PDF »
Virological, Serological, and Clinical Features of an Outbreak of Acute Gastroenteritis Due to Recombinant Genogroup II Norovirus in an Infant Home.
T. Tsugawa, K. Numata-Kinoshita, S. Honma, S. Nakata, M. Tatsumi, Y. Sakai, K. Natori, N. Takeda, S. Kobayashi, and H. Tsutsumi (2006)
J. Clin. Microbiol. 44, 177-182
   Abstract »    Full Text »    PDF »
Evolution of a rare vaccine-derived multirecombinant poliovirus.
I. Karakasiliotis, E. Paximadi, and P. Markoulatos (2005)
J. Gen. Virol. 86, 3137-3142
   Abstract »    Full Text »    PDF »
Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient.
C.-F. Yang, H.-Y. Chen, J. Jorba, H.-C. Sun, S.-J. Yang, H.-C. Lee, Y.-C. Huang, T.-Y. Lin, P.-J. Chen, H. Shimizu, et al. (2005)
J. Virol. 79, 12623-12634
   Abstract »    Full Text »    PDF »
A Sabin 3-Derived Poliovirus Recombinant Contained a Sequence Homologous with Indigenous Human Enterovirus Species C in the Viral Polymerase Coding Region.
M. Arita, S.-L. Zhu, H. Yoshida, T. Yoneyama, T. Miyamura, and H. Shimizu (2005)
J. Virol. 79, 12650-12657
   Abstract »    Full Text »    PDF »
A Dynamic Model of Poliomyelitis Outbreaks: Learning from the Past to Help Inform the Future.
R. J. Duintjer Tebbens, M. A. Pallansch, O. M. Kew, V. M. Caceres, R. W. Sutter, and K. M. Thompson (2005)
Am. J. Epidemiol. 162, 358-372
   Abstract »    Full Text »    PDF »
Seroprevalence of Poliovirus Antibodies Among Children in a Dominican Community--Puerto Rico, 2002.
(2005)
JAMA 294, 548-549
   Full Text »    PDF »
Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization.
M. Laassri, E. Dragunsky, J. Enterline, T. Eremeeva, O. Ivanova, K. Lottenbach, R. Belshe, and K. Chumakov (2005)
J. Clin. Microbiol. 43, 2886-2894
   Abstract »    Full Text »    PDF »
Virulence and competitive ability in genetically diverse malaria infections.
J. C. de Roode, R. Pansini, S. J. Cheesman, M. E. H. Helinski, S. Huijben, A. R. Wargo, A. S. Bell, B. H. K. Chan, D. Walliker, and A. F. Read (2005)
PNAS 102, 7624-7628
   Abstract »    Full Text »    PDF »
Can We Capitalize on the Virtues of Vaccines? Insights from the Polio Eradication Initiative.
R. B. Aylward and D. L. Heymann (2005)
Am J Public Health 95, 773-777
   Abstract »    Full Text »    PDF »
Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine.
E. A. Cherkasova, M. L. Yakovenko, G. V. Rezapkin, E. A. Korotkova, O. E. Ivanova, T. P. Eremeeva, L. I. Krasnoproshina, N. I. Romanenkova, N. R. Rozaeva, L. Sirota, et al. (2005)
J. Virol. 79, 1062-1070
   Abstract »    Full Text »    PDF »
High Frequency of Human Enterovirus Species C Circulation in Madagascar.
M. Rakoto-Andrianarivelo, D. Rousset, R. Razafindratsimandresy, S. Chevaliez, S. Guillot, J. Balanant, and F. Delpeyroux (2005)
J. Clin. Microbiol. 43, 242-249
   Abstract »    Full Text »    PDF »
The Elimination of Vaccine-Associated Polio in the US.
M. Dubik and L. Barton (2005)
AAP Grand Rounds 13, 9-10
   Full Text »    PDF »
Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001.
H. Shimizu, B. Thorley, F. J. Paladin, K. A. Brussen, V. Stambos, L. Yuen, A. Utama, Y. Tano, M. Arita, H. Yoshida, et al. (2004)
J. Virol. 78, 13512-13521
   Abstract »    Full Text »    PDF »
Poliomyelitis in the United States: The Final Chapter?.
J. F. Modlin (2004)
JAMA 292, 1749-1751
   Full Text »    PDF »
A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice.
A. T. Dufresne and M. Gromeier (2004)
PNAS 101, 13636-13641
   Abstract »    Full Text »    PDF »
Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses.
D. R. Kilpatrick, K. Ching, J. Iber, R. Campagnoli, C. J. Freeman, N. Mishrik, H.-M. Liu, M. A. Pallansch, and O. M. Kew (2004)
J. Clin. Microbiol. 42, 4313-4315
   Abstract »    Full Text »    PDF »
Sequence analysis of human rhinoviruses in the RNA-dependent RNA polymerase coding region reveals large within-species variation.
C. Savolainen, P. Laine, M. N. Mulders, and T. Hovi (2004)
J. Gen. Virol. 85, 2271-2277
   Abstract »    Full Text »    PDF »
Mechanism of Action at the Molecular Level of the Antiviral Drug 3(2H)-Isoflavene against Type 2 Poliovirus.
A. L. Salvati, A. De Dominicis, S. Tait, A. Canitano, A. Lahm, and L. Fiore (2004)
Antimicrob. Agents Chemother. 48, 2233-2243
   Abstract »    Full Text »    PDF »
Phylogenetic analysis of wild-type 1 polioviruses isolated during the final period of transmission in Turkey.
E. Ozkaya, H. Ishiko, R. Miura, Y. Shimada, I. Alaeddinoglu, C. Artuk, K. Miyamura, and S. Yamazaki (2004)
J. Gen. Virol. 85, 1591-1595
   Abstract »    Full Text »    PDF »
Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia.
S. Blomqvist, C. Savolainen, P. Laine, P. Hirttio, E. Lamminsalo, E. Penttila, S. Joks, M. Roivainen, and T. Hovi (2004)
J. Virol. 78, 4876-4883
   Abstract »    Full Text »    PDF »
RNA Recombination Plays a Major Role in Genomic Change during Circulation of Coxsackie B Viruses.
M. S. Oberste, S. Penaranda, and M. A. Pallansch (2004)
J. Virol. 78, 2948-2955
   Abstract »    Full Text »    PDF »
Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months.
T. Hovi, N. Lindholm, C. Savolainen, M. Stenvik, and C. Burns (2004)
J. Gen. Virol. 85, 369-377
   Abstract »    Full Text »    PDF »
Global efforts to eradicate polio.
V. F. Krym and R. D. MacDonald (2004)
Can. Med. Assoc. J. 170, 189-190
   Full Text »
Evidence for Frequent Recombination within Species Human Enterovirus B Based on Complete Genomic Sequences of All Thirty-Seven Serotypes.
M. S. Oberste, K. Maher, and M. A. Pallansch (2004)
J. Virol. 78, 855-867
   Abstract »    Full Text »    PDF »
Evidence of intratypic recombination in natural populations of hepatitis C virus.
R. Colina, D. Casane, S. Vasquez, L. Garcia-Aguirre, A. Chunga, H. Romero, B. Khan, and J. Cristina (2004)
J. Gen. Virol. 85, 31-37
   Abstract »    Full Text »    PDF »
A Single Injection of Recombinant Measles Virus Vaccines Expressing Human Immunodeficiency Virus (HIV) Type 1 Clade B Envelope Glycoproteins Induces Neutralizing Antibodies and Cellular Immune Responses to HIV.
C. Lorin, L. Mollet, F. Delebecque, C. Combredet, B. Hurtrel, P. Charneau, M. Brahic, and F. Tangy (2004)
J. Virol. 78, 146-157
   Abstract »    Full Text »    PDF »
Genetic variability of hepatitis A virus.
M. Costa-Mattioli, A. D. Napoli, V. Ferre, S. Billaudel, R. Perez-Bercoff, and J. Cristina (2003)
J. Gen. Virol. 84, 3191-3201
   Abstract »    Full Text »    PDF »
Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future.
E. A. Korotkova, R. Park, E. A. Cherkasova, G. Y. Lipskaya, K. M. Chumakov, E. V. Feldman, O. M. Kew, and V. I. Agol (2003)
J. Virol. 77, 12460-12465
   Abstract »    Full Text »    PDF »
Serial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China.
H.-M. Liu, D.-P. Zheng, L.-B. Zhang, M. S. Oberste, O. M. Kew, and M. A. Pallansch (2003)
J. Virol. 77, 10994-11005
   Abstract »    Full Text »    PDF »
Microarray analysis of evolution of RNA viruses: Evidence of circulation of virulent highly divergent vaccine-derived polioviruses.
E. Cherkasova, M. Laassri, V. Chizhikov, E. Korotkova, E. Dragunsky, V. I. Agol, and K. Chumakov (2003)
PNAS 100, 9398-9403
   Abstract »    Full Text »    PDF »
Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993.
C.-F. Yang, T. Naguib, S.-J. Yang, E. Nasr, J. Jorba, N. Ahmed, R. Campagnoli, H. van der Avoort, H. Shimizu, T. Yoneyama, et al. (2003)
J. Virol. 77, 8366-8377
   Abstract »    Full Text »    PDF »
Excretion of Wild-Type and Vaccine-Derived Poliovirus in the Feces of Poliovirus Receptor-Transgenic Mice.
H. J. Boot, D. T. J. Kasteel, A.-M. Buisman, and T. G. Kimman (2003)
J. Virol. 77, 6541-6545
   Abstract »    Full Text »    PDF »
Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.
G. Buttinelli, V. Donati, S. Fiore, J. Marturano, A. Plebani, P. Balestri, A. R. Soresina, R. Vivarelli, F. Delpeyroux, J. Martin, et al. (2003)
J. Gen. Virol. 84, 1215-1221
   Abstract »    Full Text »    PDF »
Commentary: Poliomyelitis and unnecessary injections.
N. A Halsey (2003)
Int. J. Epidemiol. 32, 278-279
   Full Text »    PDF »
Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
S. Blomqvist, A.-L. Bruu, M. Stenvik, and T. Hovi (2003)
J. Gen. Virol. 84, 573-580
   Abstract »    Full Text »    PDF »
Impaired Binding of Standard Initiation Factors Mediates Poliovirus Translation Attenuation.
K. Ochs, A. Zeller, L. Saleh, G. Bassili, Y. Song, A. Sonntag, and M. Niepmann (2002)
J. Virol. 77, 115-122
   Abstract »    Full Text »    PDF »
Isolation of an Intertypic Poliovirus Capsid Recombinant from a Child with Vaccine-Associated Paralytic Poliomyelitis.
J. Martin, E. Samoilovich, G. Dunn, A. Lackenby, E. Feldman, A. Heath, E. Svirchevskaya, G. Cooper, M. Yermalovich, and P. D. Minor (2002)
J. Virol. 76, 10921-10928
   Abstract »    Full Text »    PDF »
Imbroglios of Viral Taxonomy: Genetic Exchange and Failings of Phenetic Approaches.
J. G. Lawrence, G. F. Hatfull, and R. W. Hendrix (2002)
J. Bacteriol. 184, 4891-4905
   Abstract »    Full Text »    PDF »
Polio Outbreaks Linked to Oral Vaccine.
(2002)
Journal Watch Infectious Diseases 2002, 4
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)